These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Perilipin 5 alleviates HCV NS5A-induced lipotoxic injuries in liver. Zhang J; Gao X; Yuan Y; Sun C; Zhao Y; Xiao L; Yang Y; Gu Y; Yang R; Hu P; Zhang L; Wang C; Ye J Lipids Health Dis; 2019 Apr; 18(1):87. PubMed ID: 30954078 [TBL] [Abstract][Full Text] [Related]
6. Cardiac-specific overexpression of perilipin 5 provokes severe cardiac steatosis via the formation of a lipolytic barrier. Pollak NM; Schweiger M; Jaeger D; Kolb D; Kumari M; Schreiber R; Kolleritsch S; Markolin P; Grabner GF; Heier C; Zierler KA; Rülicke T; Zimmermann R; Lass A; Zechner R; Haemmerle G J Lipid Res; 2013 Apr; 54(4):1092-102. PubMed ID: 23345410 [TBL] [Abstract][Full Text] [Related]
7. Perilipin-5 is regulated by statins and controls triglyceride contents in the hepatocyte. Langhi C; Marquart TJ; Allen RM; Baldán A J Hepatol; 2014 Aug; 61(2):358-65. PubMed ID: 24768901 [TBL] [Abstract][Full Text] [Related]
8. Liver Perilipin 5 Expression Worsens Hepatosteatosis But Not Insulin Resistance in High Fat-Fed Mice. Trevino MB; Mazur-Hart D; Machida Y; King T; Nadler J; Galkina EV; Poddar A; Dutta S; Imai Y Mol Endocrinol; 2015 Oct; 29(10):1414-25. PubMed ID: 26296152 [TBL] [Abstract][Full Text] [Related]
9. Perilipin 5 improves hepatic lipotoxicity by inhibiting lipolysis. Wang C; Zhao Y; Gao X; Li L; Yuan Y; Liu F; Zhang L; Wu J; Hu P; Zhang X; Gu Y; Xu Y; Wang Z; Li Z; Zhang H; Ye J Hepatology; 2015 Mar; 61(3):870-82. PubMed ID: 25179419 [TBL] [Abstract][Full Text] [Related]
10. Perilipin 5 regulates islet lipid metabolism and insulin secretion in a cAMP-dependent manner: implication of its role in the postprandial insulin secretion. Trevino MB; Machida Y; Hallinger DR; Garcia E; Christensen A; Dutta S; Peake DA; Ikeda Y; Imai Y Diabetes; 2015 Apr; 64(4):1299-310. PubMed ID: 25392244 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of PLIN5 in skeletal muscle promotes oxidative gene expression and intramyocellular lipid content without compromising insulin sensitivity. Bosma M; Sparks LM; Hooiveld GJ; Jorgensen JA; Houten SM; Schrauwen P; Kersten S; Hesselink MK Biochim Biophys Acta; 2013 Apr; 1831(4):844-52. PubMed ID: 23353597 [TBL] [Abstract][Full Text] [Related]
12. Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins. Zhang W; Yang X; Chen Y; Hu W; Liu L; Zhang X; Liu M; Sun L; Liu Y; Yu M; Li X; Li L; Zhu Y; Miao QR; Han J; Duan Y Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Feb; 1863(2):177-190. PubMed ID: 29217477 [TBL] [Abstract][Full Text] [Related]
13. Deletion of Perilipin 5 Protects Against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation. Asimakopoulou A; Engel KM; Gassler N; Bracht T; Sitek B; Buhl EM; Kalampoka S; Pinoé-Schmidt M; van Helden J; Schiller J; Weiskirchen R Cells; 2020 May; 9(6):. PubMed ID: 32481590 [TBL] [Abstract][Full Text] [Related]
14. Perilipin 5 restores the formation of lipid droplets in activated hepatic stellate cells and inhibits their activation. Lin J; Chen A Lab Invest; 2016 Jul; 96(7):791-806. PubMed ID: 27135793 [TBL] [Abstract][Full Text] [Related]
15. Disruption of Plin5 degradation by CMA causes lipid homeostasis imbalance in NAFLD. Ma SY; Sun KS; Zhang M; Zhou X; Zheng XH; Tian SY; Liu YS; Chen L; Gao X; Ye J; Zhou XM; Wang JB; Han Y Liver Int; 2020 Oct; 40(10):2427-2438. PubMed ID: 32339374 [TBL] [Abstract][Full Text] [Related]
16. Acetylcholine reduces palmitate-induced cardiomyocyte apoptosis by promoting lipid droplet lipolysis and perilipin 5-mediated lipid droplet-mitochondria interaction. Wu Q; Zhao M; He X; Xue R; Li D; Yu X; Wang S; Zang W Cell Cycle; 2021 Sep; 20(18):1890-1906. PubMed ID: 34424820 [TBL] [Abstract][Full Text] [Related]